2
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T27271 | Enzaplatovir | BTAC585,BTA 585,BTA585,BTA-C585,BTA-585 | RSV |
Enzaplatovir (BTA-585) is an orally available fusion inhibitor with antiviral activity for the study of respiratory syncytial virus infections and coronavirus disease (COVID-19) infections. | |||
T37883 | (S)-Enzaplatovir | ||
(S)-Enzaplatovir ((S)-BTA-C585) is the S-enantiomer of Enzaplatovir. (S)-Enzaplatovir shows antiviral activities with an EC50 of 56 nM for respiratory syncytial viral (RSV)[1]. |